Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Sell
239,890
-39,024
-14% -$122K 0.01% 736
2026
Q1
$814K Buy
278,914
+267,644
+2,375% +$765K 0.01% 658
2025
Q4
$27.8K Sell
11,270
-296,999
-96% -$707K ﹤0.01% 1192
2025
Q3
$687K Buy
308,269
+211,568
+219% +$484K 0.01% 564
2025
Q2
$233K Sell
96,701
-1,800
-2% -$4.38K ﹤0.01% 1277
2025
Q1
$230K Buy
+98,501
New +$197K 0.01% 1227
2024
Q4
Sell
-99,391
Closed -$243K 1599
2024
Q3
$243K Buy
+99,391
New +$223K ﹤0.01% 1710
2023
Q1
Sell
-24,657
Closed -$67.1K 1475
2022
Q4
$67.1K Buy
+24,657
New +$71.8K ﹤0.01% 1236
2022
Q3
Sell
-39,421
Closed -$99K 1444
2022
Q2
$99K Buy
+39,421
New +$112K ﹤0.01% 1429

Other funds holding ABEV

Centiva Capital's ABEV Position: Q2 2026 in Review

Centiva Capital reduced its Ambev (ABEV) stake by 14% in Q2 2026, selling an estimated $122K and leaving 239,890 shares worth $753K. The position accounts for 0.01% of the portfolio, ranked #736.

Centiva Capital first reported a position in ABEV in Q2 2022 and has held it in 9 quarters since. The position peaked at $814K in Q1 2026. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Centiva Capital held 239,890 shares of Ambev worth $753K as of Q2 2026.
  • Centiva Capital sold 39,024 Ambev shares in Q2 2026, an estimated $122K.
  • Ambev made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #736 holding.
  • Centiva Capital first reported a position in Ambev in Q2 2022 and has held it in 9 quarters since.
  • Centiva Capital's Ambev position peaked at $814K in Q1 2026.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.